Oncology

Soft chemotherapy ‘effective in older breast cancer patients’

A combination of ‘soft’ chemotherapy with antiHER2 therapy has been found to be highly active and present low toxicity for older patients with HER2 positive metastatic breast cancer. According to the scientists who made the discovery, this is important in a frail population. Professor...

Mother’s breast cancer type may affect newborn health status

For breast cancer survivors, the risk of giving birth prematurely may depend on the type of breast cancer they had. This is according to a new study from the University of North Carolina Lineberger Comprehensive Cancer Center, US. The researchers analysed health indicators for children born to...

UK breast cancer mortality rate drops by 10.4%

The number of women surviving breast cancer in the UK has increased by 10.4 per cent over the past few years, according to new figures. Data released by Cancer Research UK to coincide with World Cancer Day on Sunday February 4th shows that in 2010, 39 women in every 100,000 in Britain died from...

Interactive tool ‘boosts knowledge of breast cancer treatment options’

Scientists have developed an interactive online tool to help breast cancer patients better understand their treatment options. According to Dr Sarah Hawley, professor of internal medicine at the University of Michigan, US, knowledge is a key component of making decisions about treatment, but it...

Fish-derived omega-3 ‘better than flaxseed at preventing breast cancer’

Omega-3 from fish is more effective at preventing breast cancer than flaxseed, a new study has revealed. The research, conducted by the University of Guelph, Canada, found that marine-based omega-3 is eight times more effective at inhibiting tumour development and growth. Professor David Ma, from...

Study reveals protein playing key role in spread of breast cancer

Researchers have identified how breast cancer spreads to the lungs, which could potentially hold the key to preventing the progression of the disease. According to the scientists from the University of Liverpool, UK, breast cancer remains the leading cause of cancer death in women due to metastasis...

New test identifies BRCA2 gene mutations that lead to cancers

Researchers at the Mayo Clinic, US, have developed a new test that shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. Dr Fergus Couch, lead author of the study, said: “Certain inherited mutations in the BRCA2 gene have been linked to breast...

Body shame ‘stopping young women attending cervical cancer screening’

Young women are too embarrassed to attend smear tests because of their body shape, the appearance of their genitals and concerns over smelling “normally”, according to a new survey by Jo’s Cervical Cancer Trust, UK. The survey of women aged between 25 and 35 found that 35 per cent...

Two new breast cancer genes discovered

Researchers have discovered two new breast cancer genes, which approximately double a woman’s risk of developing breast cancer by the age of 60. The genes - MSH6 and PMS2 - were discovered by researchers at Columbia University Irving Medical Center and New York-Presbyterian Hospital, US...

Population screening for breast and ovarian cancer mutations ‘is cost-effective’

Screening the entire population for breast and ovarian cancer gene mutations, not just those at high-risk of carrying the mutation, is cost-effective and could prevent more cancers. This is according to research carried out by the Barts Cancer Institute at Queen Mary University of London and Barts...